| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/08/2005 | EP1537145A1 Pharmaceutical compositions and medical treatments comprising notch ligand proteins |
| 06/08/2005 | EP1537143A2 Immunogenic muc1 glycopeptides |
| 06/08/2005 | EP1537140A2 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 06/08/2005 | EP1537138A2 Receptors and membrane-associated proteins |
| 06/08/2005 | EP1536838A1 Conjugated hydroxyalkyl starch allergen compounds |
| 06/08/2005 | EP1536837A1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 06/08/2005 | EP1536832A2 Flagellin peptides as adjuvants for vaccines |
| 06/08/2005 | EP1536831A2 Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides |
| 06/08/2005 | EP1536830A1 Vaccine for respiratory and reproductive system infections in cattle |
| 06/08/2005 | EP1536829A2 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease |
| 06/08/2005 | EP1536828A2 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 06/08/2005 | EP1536825A1 Interferon and immunoglobulin fc fragment hybrid |
| 06/08/2005 | EP1536820A2 Cancer therapy using whole glucan particles and antibodies |
| 06/08/2005 | EP1536815A1 Angio-immunotherapy |
| 06/08/2005 | EP1536814A2 Antibodies to non-shed muc1 and muc16, and uses thereof |
| 06/08/2005 | EP1536778A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 06/08/2005 | EP1536769A2 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
| 06/08/2005 | EP1206488B1 Method for isolating and purifying grass pollen allergens |
| 06/08/2005 | EP1097174B1 Lupus anticoagulant antibody to f1 region of prothrombin |
| 06/08/2005 | EP1024806B1 Use of non-immunosuppressive compounds for promoting nerve regeneration |
| 06/08/2005 | EP0997152B1 Antibodies as REMEDIES FOR LYMPHOCYTIC TUMORS (EXCEPT MYELOMA) |
| 06/08/2005 | EP0793504B1 Chimeric cytokines and uses thereof |
| 06/08/2005 | EP0777738B1 Condii toxoplasma p30 expression cassette |
| 06/08/2005 | CN1625567A Novel monoclonal antibody and nematode larval antigens |
| 06/08/2005 | CN1625565A Antibodies to non-functional P2X7 receptor, diagnosis and treatment of cancers and other conditions |
| 06/08/2005 | CN1625409A Immunogen preparation of variable peptidic epitopes and preparation method thereof |
| 06/08/2005 | CN1624143A Recombined pseudorabies virus of expressing pig influenza virus hemagglutinin gene and application |
| 06/08/2005 | CN1624141A Process for raising expressing content of colyliform virus VPT or VP4 in plant and its product |
| 06/08/2005 | CN1624128A Death domain containing receptor 5 antibodies |
| 06/08/2005 | CN1624126A Ret ligand (retl) for stimulating neural and renal growth |
| 06/08/2005 | CN1624116A Artificial recombined influenza virus and its application |
| 06/08/2005 | CN1624115A Cell surface molecule mediating cell adhesion and signal transmission |
| 06/08/2005 | CN1623604A Process for controlling birth female of mammal based on SRY gene |
| 06/08/2005 | CN1623603A Immunologic adjuvant and vaccine contacning said adjuvant |
| 06/08/2005 | CN1623602A Vaccines |
| 06/08/2005 | CN1623601A Attenuated live vaccine of vibrion from eel |
| 06/08/2005 | CN1205223C Insect poison allergens with reduced LgE reactivity and method for producing the same |
| 06/08/2005 | CN1205222C Method for isolating and purifying grass pollen allergens |
| 06/08/2005 | CN1205217C Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them |
| 06/08/2005 | CN1204924C Liquid composition of biodegradable block copolymer for drug delivery system and process for preparation thereof |
| 06/07/2005 | US6903204 Polynucleotides encoding methionyl tRNA synthetase from Staphylococcus aureus, related products and methods |
| 06/07/2005 | US6903203 Immunoglobulin for use in the diagnosis and therapy of cancer |
| 06/07/2005 | US6903194 Antibody against human parathormone related peptides |
| 06/07/2005 | US6903184 Multiple antigenic peptides immunogenic against Streptococcus pneumonia |
| 06/07/2005 | US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 06/07/2005 | US6903100 Administering methotrexate at high level to cross the blood brain barrier; methotrexate administration is accompanied by leucovorin rescue of the periphery |
| 06/07/2005 | US6903096 Quinazoline derivatives as medicaments |
| 06/07/2005 | US6902926 For production of vaccines; fusion proteins |
| 06/07/2005 | US6902910 Death domain containing receptor 4 |
| 06/07/2005 | US6902906 Bacteria attenuated by a non-reverting mutation in each of the aroC, ompF and ompC genes, useful as vaccines |
| 06/07/2005 | US6902893 Lyme disease vaccines |
| 06/07/2005 | US6902890 Method of diagnosing monitoring, staging, imaging and treating cancer |
| 06/07/2005 | US6902885 For detecting viral and cellular polypeptide interactions |
| 06/07/2005 | US6902736 Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same |
| 06/07/2005 | US6902735 Antibodies to human IL-17F and other CTLA-8-related proteins |
| 06/07/2005 | US6902734 Also an IL-12 anti-idiotype antibody to the antibody |
| 06/07/2005 | CA2348026C Antibodies against semp1, methods for their production and uses thereof |
| 06/07/2005 | CA2222482C Non-virulent mycoplasma synoviae and vaccine thereof |
| 06/07/2005 | CA2153135C Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them |
| 06/05/2005 | CA2449186A1 Generation of therapeutic regulatory dc by multiple gene silencing through induction of rna interference |
| 06/02/2005 | WO2005050215A1 Selection of lactic acid bacteria enhancing the immune response against streptococcus pneumoniae |
| 06/02/2005 | WO2005050213A1 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 06/02/2005 | WO2005050203A2 The methods for screening using ctgf and trka receptor for the identification of compounds for use in treatment of fibrosis |
| 06/02/2005 | WO2005050202A2 Biological materials and uses thereof |
| 06/02/2005 | WO2005050198A2 Metadherin polypeptides, encoding nucleic acids and methods of use |
| 06/02/2005 | WO2005049852A2 Methods and compositions for inducing apoptosis |
| 06/02/2005 | WO2005049837A1 Immunization against chlamydia infection |
| 06/02/2005 | WO2005049836A1 Immunization against chlamydia infection |
| 06/02/2005 | WO2005049814A2 Novel atypical pneumonia-causing virus |
| 06/02/2005 | WO2005049802A2 Anti-hydroxylase antibodies and uses thereof |
| 06/02/2005 | WO2005049794A2 Methods of characterizing infectious bursal disease virus |
| 06/02/2005 | WO2005049786A2 Modulation of angiogenesis by bartonella henselae |
| 06/02/2005 | WO2005049647A2 Compositions comprising melittin-derved peptides and methods for the potentiation of immune responses against target antigens |
| 06/02/2005 | WO2005049642A2 Genome of legionella pneumophila paris and lens strain-diagnostic and epidemiological applications |
| 06/02/2005 | WO2005049641A2 Surface-located campylobacter jejuni polypeptides |
| 06/02/2005 | WO2005049635A2 Human monoclonal antibody having fat-reducing effect |
| 06/02/2005 | WO2005049093A1 Use of microparticles for antigen delivery |
| 06/02/2005 | WO2005049084A2 Inhibition of trp channels as a treatment for cardiac hypertrophy and heart failure |
| 06/02/2005 | WO2005049081A1 The use of anti biotics as vaccine adjuvants |
| 06/02/2005 | WO2005049080A1 Vaccine composition admixed with an alkylphosphatidylcholine |
| 06/02/2005 | WO2005049079A1 Viscous, non-polymorphic, non-water soluble liquid adjuvants |
| 06/02/2005 | WO2005049078A2 Immunoglobulin preparations having increased stability |
| 06/02/2005 | WO2005049077A2 Avian vaccine effective against infectious bursal disease virus |
| 06/02/2005 | WO2005049076A1 Use of capsular neisseria meningitidis polysaccharides as mucosal immunopotentiators and resulting formulations |
| 06/02/2005 | WO2005049075A2 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 06/02/2005 | WO2005049074A2 Methods for modulating the th2 immuneresponse to an antigen by adding or removing activated carbonyl groups from the antigen |
| 06/02/2005 | WO2005049073A2 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 06/02/2005 | WO2005049072A2 Therapeutic cancer vaccine with fragments of trag-3 |
| 06/02/2005 | WO2005049067A1 Isolated complexes of endotoxin and md-2 |
| 06/02/2005 | WO2005049056A2 Immune modulator comprising whole cell rhodococcus, gordonia, nocardia, dietzia, tsukamurella or nocardioides bacteria |
| 06/02/2005 | WO2005049044A1 Oligo-beta-(1, 3) -glucan and monoclonal antibodies against cancer |
| 06/02/2005 | WO2005048997A1 Nanoparticles for delivery of a pharmacologically active agent |
| 06/02/2005 | WO2005048957A2 Novel insertion sites in pox vectors |
| 06/02/2005 | WO2005048943A2 Compositions and methods for synergistic induction of antitumor immunity |
| 06/02/2005 | WO2005048938A2 Anti-pecam therapy for metastasis suppression |
| 06/02/2005 | WO2005048935A2 Methods of modulating immunity |
| 06/02/2005 | WO2005048918A2 Anthrax vaccine |
| 06/02/2005 | WO2005048914A2 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases |
| 06/02/2005 | WO2005048822A2 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof |
| 06/02/2005 | WO2005034979A3 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |